Unraveling the binding interaction and kinetics of a prospective anti-HIV drug with a model transport protein: results and challenges

2013 ◽  
Vol 15 (4) ◽  
pp. 1275-1287 ◽  
Author(s):  
Bijan Kumar Paul ◽  
Debarati Ray ◽  
Nikhil Guchhait
2011 ◽  
Vol 439 (3) ◽  
pp. 423-434 ◽  
Author(s):  
Raphael F. Queiroz ◽  
Sandra M. Vaz ◽  
Ohara Augusto

The nitroxide tempol (4-hydroxy-2,2,6,6-tetramethyl piperidine-1-oxyl) reduces tissue injury in animal models of inflammation by mechanisms that are not completely understood. MPO (myeloperoxidase), which plays a fundamental role in oxidant production by neutrophils, is an important target for anti-inflammatory action. By amplifying the oxidative potential of H2O2, MPO produces hypochlorous acid and radicals through the oxidizing intermediates MPO-I [MPO-porphyrin•+-Fe(IV)=O] and MPO-II [MPO-porphyrin-Fe(IV)=O]. Previously, we reported that tempol reacts with MPO-I and MPO-II with second-order rate constants similar to those of tyrosine. However, we noticed that tempol inhibits the chlorinating activity of MPO, in contrast with tyrosine. Thus we studied the inhibition of MPO-mediated taurine chlorination by tempol at pH 7.4 and re-determined the kinetic constants of the reactions of tempol with MPO-I (k=3.5×105 M−1·s−1) and MPO-II, the kinetics of which indicated a binding interaction (K=2.0×10−5 M; k=3.6×10−2 s−1). Also, we showed that tempol reacts extremely slowly with hypochlorous acid (k=0.29 and 0.054 M−1·s−1 at pH 5.4 and 7.4 respectively). The results demonstrated that tempol acts mostly as a reversible inhibitor of MPO by trapping it as MPO-II and the MPO-II–tempol complex, which are not within the chlorinating cycle. After turnover, a minor fraction of MPO is irreversibly inactivated, probably due to its reaction with the oxammonium cation resulting from tempol oxidation. Kinetic modelling indicated that taurine reacts with enzyme-bound hypochlorous acid. Our investigation complements a comprehensive study reported while the present study was underway [Rees, Bottle, Fairfull-Smith, Malle, Whitelock and Davies (2009) Biochem. J. 421, 79–86].


Author(s):  
Suwicha Patnin ◽  
Arthit Makarasen ◽  
Mayuso Kuno ◽  
Sirinya Deeyohe ◽  
Supanna Techasakul ◽  
...  

2007 ◽  
Vol 74 (3) ◽  
pp. A68-A69
Author(s):  
K VERMEIRE ◽  
A LISCO ◽  
J GRIVEL ◽  
P BLANK ◽  
V SCHRAM ◽  
...  

1982 ◽  
Vol 79 (2) ◽  
pp. 169-185 ◽  
Author(s):  
M L Jennings

The kinetics of human red blood cell Cl transport have been studied under nonequilibrium conditions to determine whether or not an outward Cl gradient can recruit the transport protein from an inward-facing to an outward-facing configuration. Three kinds of evidence are consistent with this outward recruitment. First, the initial net Cl efflux into a Cl-free phosphate medium is independent of the intracellular Cl concentration in the range 20-170 mM. Second, an outward Cl gradient strongly enhances the inhibitory potency of DNDS (4,4'-dinitro-2,2'-stilbene disulfonate), which suggests that DNDS binds primarily to outward-facing states. Finally, we have estimated the number of Cl ions transported during the putative outward recruitment. Resealed red cell ghosts containing only 70 muM 36Cl were resuspended at 0 degrees C in a Cl-free, HCO3-free Na2SO4 medium. In the first 10 s, or approximately 10(6) Cl ions per ghost, followed by a much slower further loss of Cl. The rapid loss of 10(6) Cl ions per ghost, which is abolished by pretreatment with DIDS (4,4'-diisothiocyano-2,2'-stilbene disulfonate), appears to represent the Cl that is transported during the first half-turnover of the transport cycle. These data are strong evidence that the influx and efflux events in the catalytic cycle for anion transport do not take place simultaneously, and that the stoichiometry of the transport cycle is close to one pair of anions exchanged per band 3 monomer.


1991 ◽  
Vol 73 (2) ◽  
pp. 105-110 ◽  
Author(s):  
A. Van Schepdael ◽  
N. Ossembe ◽  
L. Jie ◽  
P. Herdewijn ◽  
E. Roets ◽  
...  
Keyword(s):  

RSC Advances ◽  
2015 ◽  
Vol 5 (80) ◽  
pp. 65496-65513 ◽  
Author(s):  
Himank Kumar ◽  
Vinod Devaraji ◽  
Ritika Joshi ◽  
Manojkumar Jadhao ◽  
Piyush Ahirkar ◽  
...  

The usefulness of heterocyclic chalcone derivative as a therapeutic target in controlling hypertension and its site specific binding interaction with model transport protein to get a clear picture about its delivery mechanism.


2011 ◽  
Vol 171 (2) ◽  
pp. 381-387 ◽  
Author(s):  
Kun Silprasit ◽  
Ratsupa Thammaporn ◽  
Supanna Tecchasakul ◽  
Supa Hannongbua ◽  
Kiattawee Choowongkomon

Sign in / Sign up

Export Citation Format

Share Document